Notes - Finance Income And Finance Costs

Sumitomo Pharma Co., Ltd. - Filing #7249083

Concept 2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
Notes - Finance income and finance costs
Components of finance income and finance costs
Finance income
Interest income
Financial assets measured at amortized cost
890,000,000 JPY
2,019,000,000 JPY
Other
886,000,000 JPY
354,000,000 JPY
Finance income
2,307,000,000 JPY
36,022,000,000 JPY
Finance costs
Interest expenses
Financial liabilities measured at amortized cost
6,221,000,000 JPY
3,893,000,000 JPY
Other
2,337,000,000 JPY
384,000,000 JPY
Finance costs
13,500,000,000 JPY
4,277,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.